LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 14 May 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
815,510 |
0.63% |
509,043 |
0.40% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
642,000 |
0.50% |
368,818 |
0.29% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
| TOTAL: |
|
|
|
|
|
1,457,510 |
1.13% |
877,861 |
0.68% |
||
|
|
|
|
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities |
Price per unit |
| Purchase | 2 |
195.5650 USD |
| Purchase | 79 |
199.3722 USD |
| Purchase | 92 |
198.4600 USD |
| Purchase | 100 |
195.3900 USD |
| Purchase | 100 |
198.1100 USD |
| Purchase | 100 |
198.9800 USD |
| Purchase | 135 |
195.8300 USD |
| Purchase | 181 |
198.8393 USD |
| Purchase | 785 |
201.6278 USD |
| Purchase | 787 |
197.9219 USD |
| Purchase | 941 |
200.1759 USD |
| Purchase | 1,040 |
201.0570 USD |
| Purchase | 1,272 |
201.1833 USD |
| Purchase | 1,400 |
200.2049 USD |
| Purchase | 4,434 |
200.5222 USD |
| Purchase | 4,511 |
196.6924 USD |
| Purchase | 6,409 |
198.9013 USD |
| Purchase | 10,000 |
199.1979 USD |
| Purchase | 10,357 |
197.9530 USD |
| Purchase | 24,707 |
201.6600 USD |
| Purchase | 33,447 |
199.6415 USD |
| Purchase | 146,918 |
201.5374 USD |
| Sale | 2 |
201.4000 USD |
| Sale | 4 |
201.7275 USD |
| Sale | 6 |
200.1316 USD |
| Sale | 6 |
201.2100 USD |
| Sale | 6 |
200.9800 USD |
| Sale | 8 |
200.9912 USD |
| Sale | 8 |
194.9800 USD |
| Sale | 10 |
200.7240 USD |
| Sale | 13 |
201.4853 USD |
| Sale | 14 |
201.4992 USD |
| Sale | 14 |
201.4071 USD |
| Sale | 79 |
199.3722 USD |
| Sale | 100 |
193.7800 USD |
| Sale | 100 |
195.3300 USD |
| Sale | 100 |
200.2400 USD |
| Sale | 100 |
201.8600 USD |
| Sale | 100 |
201.8700 USD |
| Sale | 100 |
201.8900 USD |
| Sale | 100 |
201.9550 USD |
| Sale | 101 |
198.9107 USD |
| Sale | 135 |
195.8300 USD |
| Sale | 192 |
198.1008 USD |
| Sale | 212 |
198.8000 USD |
| Sale | 245 |
196.9830 USD |
| Sale | 292 |
196.3293 USD |
| Sale | 296 |
201.2987 USD |
| Sale | 300 |
197.7433 USD |
| Sale | 387 |
197.9433 USD |
| Sale | 400 |
198.1500 USD |
| Sale | 429 |
197.6962 USD |
| Sale | 475 |
199.9810 USD |
| Sale | 493 |
199.7941 USD |
| Sale | 785 |
201.6278 USD |
| Sale | 800 |
199.8650 USD |
| Sale | 1,010 |
200.4044 USD |
| Sale | 1,127 |
197.9444 USD |
| Sale | 1,305 |
201.6503 USD |
| Sale | 1,332 |
200.2309 USD |
| Sale | 1,711 |
195.0994 USD |
| Sale | 1,835 |
196.9041 USD |
| Sale | 2,957 |
196.7698 USD |
| Sale | 3,900 |
198.8451 USD |
| Sale | 6,100 |
199.4234 USD |
| Sale | 7,342 |
196.6439 USD |
| Sale | 15,112 |
198.9903 USD |
| Sale | 24,561 |
201.6600 USD |
| Sale | 28,833 |
200.4652 USD |
| Sale | 144,309 |
201.5868 USD |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction |
Number of relevant securities |
Price per |
|
|
unit |
|
| SWAP | Short |
470 |
197.6401 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 15 May 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |